Samsung BioLogics sets sights on Korean IPO

Contract manufacturer Samsung BioLogics (Seoul, South Korea) is planning to list shares in South Korea this year. The company plans to select lead managers next month before deciding on the number of shares and timing.

Samsung BioLogics is a JV formed in 2011 by Samsung Group (Seoul, South Korea) and CRO Quintiles Transnational Holdings Inc. (NYSE:Q) to give Samsung access to manufacturing capabilities. ...